Literature DB >> 2972772

Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis.

Y Fujii1, J Lindstrom.   

Abstract

Ten acetylcholine receptor (AChR)-specific T cell clones from Lewis rats were studied. These clones had various AChR subunit and peptide specificities, and proliferated in response to antigen on appropriate APC. All the T cell clones were CD4+CD8- and OX22-, helped anti-AChR antibody production by AChR-primed lymph node B cells, and could secrete IL-2. However, several lines of evidence suggested that IL-2 was not the lymphokine that mediated T cell help. B cells primed with native AChR and then exposed in culture to very low concentrations of native AChR effectively presented the Ag to the T cell lines, presumably due to uptake via Ag receptors, but primed B cells were no more effective than were non-specific APC at presenting a synthetic AChR peptide which is recognized by AChR-specific T cells but not by AChR-specific B cells. Increasing AChR doses produced an antibody production response that was bell shaped and low doses stimulated, whereas higher AChR concentrations suppressed the antibody production response. Evidence suggested that AChR exerted its inhibitory effect through the T cells, but not via IL-2.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972772

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Expansion of regulatory T cells via IL-2/anti-IL-2 mAb complexes suppresses experimental myasthenia.

Authors:  Ruolan Liu; Qinghua Zhou; Antonio La Cava; Denise I Campagnolo; Luc Van Kaer; Fu-Dong Shi
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

Review 2.  B cells in the pathophysiology of myasthenia gravis.

Authors:  John S Yi; Jeffrey T Guptill; Panos Stathopoulos; Richard J Nowak; Kevin C O'Connor
Journal:  Muscle Nerve       Date:  2017-09-30       Impact factor: 3.217

3.  Characterization of rat T-cell clones with bacterial specificity.

Authors:  J W Eastcott; K Yamashita; M A Taubman; D J Smith
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

4.  Characterization of rat T helper cell clones specific for Bacteroides gingivalis antigen.

Authors:  J Katz; S M Michalek; K W Beagley; J H Eldridge
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.

Authors:  F D Shi; X F Bai; H L Li; Y M Huang; P H Van der Meide; H Link
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

6.  'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies.

Authors:  I Ohtsuru; H Matsuo; T Fukudome; A Suenaga; M Tsujihata; S Nagataki
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

7.  The MRC OX-22- CD4+ T cells that help B cells in secondary immune responses derive from naive precursors with the MRC OX-22+ CD4+ phenotype.

Authors:  F Powrie; D Mason
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.